Matches in Wikidata for { <http://www.wikidata.org/entity/Q65350718> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q65350718 description "clinical trial" @default.
- Q65350718 description "ensayu clínicu" @default.
- Q65350718 description "klinisch onderzoek" @default.
- Q65350718 description "клінічне випробування" @default.
- Q65350718 name "Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)" @default.
- Q65350718 name "Efficacy and Safety of Grazoprevir" @default.
- Q65350718 type Item @default.
- Q65350718 label "Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)" @default.
- Q65350718 label "Efficacy and Safety of Grazoprevir" @default.
- Q65350718 prefLabel "Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)" @default.
- Q65350718 prefLabel "Efficacy and Safety of Grazoprevir" @default.
- Q65350718 P1050 Q65350718-75F6F041-7C4C-4E34-B8CF-6319F339E6CF @default.
- Q65350718 P1050 Q65350718-7BC32612-4A86-44BE-923D-4DA3F64E89E9 @default.
- Q65350718 P1050 Q65350718-D47A3FC1-3CD9-45A2-9BFB-A5D8141E8813 @default.
- Q65350718 P1132 Q65350718-46E6C387-A80B-4CDB-8990-59C43927006D @default.
- Q65350718 P1476 Q65350718-7D8961F2-3DFB-4EB8-83F3-F0A617CF25DF @default.
- Q65350718 P2899 Q65350718-F62E35D8-7987-4D48-A558-48816FFEDA64 @default.
- Q65350718 P3098 Q65350718-0EF7F58D-4B08-44BE-8D1D-31E0CF900358 @default.
- Q65350718 P31 Q65350718-3C424739-8BB3-48BF-B858-AEBC719C1292 @default.
- Q65350718 P4844 Q65350718-8F09C467-D661-4A14-9FAC-4D2D0E80E93C @default.
- Q65350718 P580 Q65350718-07476D5B-717D-45FF-B811-4EBF40E0CE4F @default.
- Q65350718 P582 Q65350718-9C6E1818-CA28-4382-91FA-CFA058A68C22 @default.
- Q65350718 P6099 Q65350718-3B904570-39C7-4953-A299-10B9E018447D @default.
- Q65350718 P8363 Q65350718-85214D74-8F0E-455D-8DA2-18483AB425B6 @default.
- Q65350718 P1050 Q131742 @default.
- Q65350718 P1050 Q154869 @default.
- Q65350718 P1050 Q157661 @default.
- Q65350718 P1132 "+443" @default.
- Q65350718 P1476 "A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-3682 With Either MK-8742 or MK-8408 in Subjects With Chronic HCV GT1 and GT2 Infection" @default.
- Q65350718 P2899 "+18" @default.
- Q65350718 P3098 "NCT02332707" @default.
- Q65350718 P31 Q30612 @default.
- Q65350718 P4844 Q27281714 @default.
- Q65350718 P580 "2015-01-22T00:00:00Z" @default.
- Q65350718 P582 "2016-09-16T00:00:00Z" @default.
- Q65350718 P6099 Q42824440 @default.
- Q65350718 P8363 Q78089383 @default.